The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review
Authors:
- 8 January 2018
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 34 (7) , 545-550
Abstract
The aim of this review is to present the current data about the role of inositols in the management of polycystic ovary syndrome (PCOS) women and in the prevention and treatment of gestational diabetes mellitus (GDM). We analyzed the available literature with key words PCOS, Myo-inositol, D-chiro-inositol, assisted reproductive technologies and GDM. The most recent literature would suggest that Myo-inositol, D-chiro-inositol and their combination in physiological ratio 40:1 could represent an important therapeutic strategy for the improvement of metabolic, hormonal and reproductive aspects of PCOS. In assisted reproductive technologies, however, myo-inositol and the combined treatment, despite D-chiro-inositol monotherapy, are able to improve clinical outcomes. Myo-inositol monotherapy results more effective in preventing and treating GDM even if a larger cohort of studies is needed to better clarify these results.Keywords
This publication has 55 references indexed in Scilit:
- CONCERN: Does ovary need D-chiro-inositol?Journal of Ovarian Research, 2012
- Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot studyReproductive Biology and Endocrinology, 2012
- The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetesDiabetic Medicine, 2011
- d-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic reviewGynecological Endocrinology, 2010
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndromeGynecological Endocrinology, 2009
- Insulin-stimulated release of d-chiro-inositol–containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndromeMetabolism, 2008
- Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolismHuman Reproduction, 2008
- Current Approaches to the Diagnosis and Treatment of Polycystic Ovarian Syndrome in YouthHormone Research in Paediatrics, 2007
- Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controlsBiochemical and Biophysical Research Communications, 2002
- Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary SyndromeNew England Journal of Medicine, 1999